Additionally, it would be important to further investigate the additive value of other standard clinically measured variables like creatinine, haemoglobin, albumin, and measurements of liver enzymes that have been described to vary in different hepatopancreaticobiliary patient groups [43], and also in combination with novel tumour specific blood-based biomarkers. The gene discussed is ALB; the disease is neoplasm.